InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
8
Disclosed sells
0
T+90 hit rate
76%
T+90 mean return
+12.6%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Coric Vlad, Chief Executive Officer. Insider active across 4 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 27 reports have been logged. Split: 8 buys · 0 sell. Total volume traded: €25.8m. Activity tracked since 25 November 2021. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations27 total
4,545 shares0Class A Ordinary SharesSEC:0001704317-26-000006:0
7,614 shares0Class A Ordinary SharesSEC:0001802768-25-000047:0
3,184 shares0Class A Ordinary SharesSEC:0001802768-25-000023:0
5,784 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015343:0
14,250 shares0Common SharesSEC:0001935979-25-000002:0
21,052 shares@ US$47.503.5% of flowCommon SharesSEC:0001935979-24-000077:0
Ideal exit: 29 Jun 2025 (T+270)
15,000 shares0Common StockSEC:0001479290-24-000085:0
121,951 shares@ US$41.0018.2% of flowCommon SharesSEC:0001562180-24-003493:0
Ideal exit: 17 Jan 2025 (T+270)
232 sharesCommon SharesSEC:0001562180-24-003336:0
2,162 sharesCommon SharesSEC:0001562180-24-002509:0
5,400 sharesCommon SharesSEC:0001562180-24-000426:0
340,908 shares@ US$22.0027.6% of flowCommon ShareSEC:0001562180-23-007246:0
Ideal exit: 1 Jul 2024 (T+270)
113,637 shares@ US$22.009.2% of flowCommon SharesSEC:0001562180-23-007246:1
Ideal exit: 1 Jul 2024 (T+270)
589 shares0Common StockSEC:0001479290-23-000059:0
5,195 shares0Common StockSEC:0001479290-23-000033:0
25,800 shares@ US$15.96881.6% of flowCommon StockSEC:0001562180-22-007386:0
Ideal exit: 28 Jul 2023 (T+270)
41,930 shares@ US$14.86652.4% of flowCommon SharesSEC:0001562180-22-007373:0
Ideal exit: 25 Jul 2023 (T+270)
853,380 shares@ US$10.5034.9% of flowCommon SharesSEC:0001562180-22-007332:0
Ideal exit: 22 Jul 2023 (T+270)
00Common SharesSEC:0001562180-22-007176:0
73,331 shares@ US$8.82342.5% of flowCommon SharesSEC:0001562180-22-007115:0
Ideal exit: 2 Jul 2023 (T+270)
46,025 shares0Common SharesSEC:0001562180-22-007103:0
461,470 shares0Common SharesSEC:0001562180-22-007074:0
92,050 shares@ US$148.50100.0% of flowCommon SharesSEC:0001562180-22-006963:0
12,500 shares0Common SharesSEC:0001562180-22-000350
12,500 shares0Common SharesSEC:0001562180-22-000350:0
25 of 27 declarations
About Coric Vlad
Coric Vlad is the Chief Executive Officer of Biohaven Pharmaceutical Holding Co Ltd. In this role, he is responsible for the strategic and operational direction of the company. His expertise in the pharmaceutical sector allows him to develop innovative treatments and meet patient needs. He plays a key role in the growth and success of Biohaven.
